The modern system of drug discovery and development is broken. Development costs are so high that pharmaceutical companies can only afford to develop blockbuster drugs that will be worth at least $1 billion annually and take a decade to come to market. Researchers have incentives to hide their work rather than collaborate. And the most valuable data for drug discovery is hidden in silos or unpublished research. Entrepreneur Gunjan Bhardwaj, CEO of...

"In the near future, Berlin's real estate is being flipped in the name of "sustainability," only to make the city even more unaffordable; artists are employed by corporations as consultants; and the weather is acting strange. In search of affordable housing, young couple Anja and Louis move into a community on an artificial mountain, The Berg--yet another "eco-friendly" initiative run by a corporation called Finster. They're offered a home rent-free...

"For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug, and how the core team--denied their share of the profits--went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time. In the multibillion-dollar...

"A deeply human story, Fentanyl, Inc. is the first deep-dive investigation of a hazardous and illicit industry that has created a worldwide epidemic, ravaging communities and overwhelming and confounding government agencies that are challenged to combat it. "A whole new crop of chemicals is radically changing the recreational drug landscape," writes Ben Westhoff. "These are known as Novel Psychoactive Substances (NPS) and they include replacements...